69 Biotech Startups to Watch (and Work for) in 2023
The Biotech tech sector in Europe booming. In 2022, Biotech raised $5.2 Billion in capital (after raising $5 Billion in 2021). Whether you're an experienced investor, a determined founder, or a resourceful operator this year's list of top 69 tech startups is worth exploring. It includes companies of various sizes, ranging from those experiencing rapid growth to smaller, creative startups.
Last update: September 08, 2023
Featured companies in Biotech
Get access to the Seedtable database with +15,000 companies (839 from Biotech)Featured
Biomedical research discovery tool.
-
Latest Funding
$60 Million · Series B
-
Employees
51 to 100
-
Investors
Marathon VC, Pentech Ventures, ICONIQ Growth, Index Ventures
-
Business Model
B2B, SAAS
-
Industries
Health Tech, AI, Biotech, Pharma
-
Locations
London
-
Contact
•••••@causaly.com
Unlock contact info
Featured
Ultrasound-based medical device to treat a wide range of brain disorders.
-
Latest Funding
$41 Million · Series B
-
Employees
1 to 10
-
Investors
Panakes Partners, EIC Accelerator
-
Industries
Health Tech, Biotech
-
Locations
Paris
-
Contact
•••••@carthera.eu
Unlock contact info
Featured
Preclinical stage treatment for geographic atrophy.
-
Latest Funding
$79 Million · Series A
-
Employees
1 to 10
-
Investors
Forbion Capital Partners, Gimv
-
Industries
Biotech
-
Locations
London
-
Contact
•••••@complementtx.com
Unlock contact info
List of 69 top tech companies in Biotech
Get access to the Seedtable database with +15k companies (839 from Biotech)Oophthalmic gene therapy company to treat blinding retinal illnesses.
-
Latest Funding
$120 Million · Series A
-
Industries
Health Tech, Biotech
-
Locations
London
-
Employees
1 to 10
-
Investors
Syncona Partners LLP
-
Contact
•••••@beacontx.com
Unlock contact info
Developer of bio-fabricated silk protein materials.
-
Latest Funding
$27 Million · Series C
-
Industries
Health Tech, Biotech, Manufacturing
-
Locations
Munich
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Novo A/S
-
Contact
•••••@amsilk.com
Unlock contact info
Producer of gut health binding proteins.
-
Latest Funding
$33 Million · Series A
-
Industries
Biotech, Pharma
-
Locations
Copenhagen
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Bill & Melinda Gates Foundation, Novo A/S
-
Contact
•••••@bactolife.com
Unlock contact info
Clinical trials platform.
-
Latest Funding
$18 Million · Series A
-
Industries
Health Tech, Biotech
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B, SAAS
-
Investors
Valar Ventures, Creandum, Hambro Perks Ltd., Firstminute Capital, Seedcamp, Atomico, Calm/Storm Ventures
-
Contact
•••••@lindushealth.com
Unlock contact info
Mnemo Therapeutics specializes in biotechnology and life science.
-
Latest Funding
$90 Million · Series A
-
Industries
Health Tech, Biotech
-
Locations
Paris
-
Employees
101 to 250
-
Business Model
B2B
-
Investors
Sofinnova Partners
-
Contact
•••••@mnemo-tx.com
Unlock contact info
SparingVision is a biotechnology company focused development of genomic medicines for the treatment of blinding inherited retinal diseases.
-
Latest Funding
$53 Million · Series A
-
Industries
Health Tech, Biotech, Deep Tech
-
Locations
Paris
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Ysios Capital
-
Contact
•••••@sparingvision.com
Unlock contact info
Gene therapies for inherited retinal disorders.
-
Latest Funding
$65 Million · Series A
-
Industries
Biotech
-
Locations
Milan
-
Employees
1 to 10
-
Investors
Forbion Capital Partners
-
Contact
•••••@aavantgardebio.com
Unlock contact info
Automated bioprocessing system for the production of cell and gene therapies.
-
Latest Funding
$18 Million · Seed
-
Industries
Biotech
-
Locations
Paris
-
Employees
11 to 50
-
Investors
AdBio Partners
-
Contact
•••••@astraveus.com
Unlock contact info
Medical devices for a transvascular treatment of pulmonary hypertension.
-
Latest Funding
$15 Million · Series A
-
Industries
Health Tech, Biotech
-
Locations
Paris
-
Employees
1 to 10
-
Investors
Sofinnova Partners, Asabys Partners
-
Contact
•••••@gradientdenervation.com
Unlock contact info
Anti-cancer drug developer.
-
Latest Funding
$34 Million · Series A
-
Industries
Health Tech, Biotech
-
Locations
Copenhagen
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Ysios Capital, HealthCap
-
Contact
•••••@adcendo.dk
Unlock contact info
Innovative immunotherapies developer for cancer patients.
-
Latest Funding
$52 Million
-
Industries
Health Tech, Biotech, Manufacturing
-
Locations
Munich
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Forbion Capital Partners, Vesalius Biocapital Partners, Novartis Venture Fund, Bayern Kapital, Coparion
-
Contact
•••••@catalym.com
Unlock contact info
Treatments for genetic bleeding disorders.
-
Latest Funding
$140 Million · Series B
-
Industries
Health Tech, Biotech, Deep Tech, Pharma
-
Locations
Copenhagen
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
HealthCap, Novo A/S
-
Contact
•••••@hemab.com
Unlock contact info
Vaccine for Group B Streptococcus.
-
Latest Funding
$23 Million · Series C
-
Industries
Health Tech, Biotech, Deep Tech
-
Locations
Copenhagen
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
European Investment Bank, Pureos Bioventures, Wellington Partners, Industrifonden
-
Contact
•••••@minervax.com
Unlock contact info
Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments.
-
Latest Funding
$100 Million · Series B
-
Industries
Health Tech, Biotech, Manufacturing
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Kindred Capital, Octopus Ventures, Amadeus Capital
-
Contact
•••••@oribiotech.com
Unlock contact info
Quell Therapeutics is a cell therapy company
-
Latest Funding
$160 Million · Series B
-
Industries
Health Tech, Edtech, Biotech, Manufacturing
-
Locations
London
-
Employees
101 to 250
-
Business Model
B2B
-
Investors
Point72 Ventures, AlbionVC
-
Contact
•••••@quell-tx.com
Unlock contact info
Tropic Biosciences is a pioneering leader in the development of novel high-performing commercial tropical crop varieties and traits.
-
Latest Funding
$35 Million · Series C
-
Industries
Agritech, Biotech, Deep Tech, Manufacturing
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Future Planet Capital
-
Contact
•••••@tropicbioscience.com
Unlock contact info
Platform to automate the clinical studies process.
-
Latest Funding
$12 Million · Series A
-
Industries
Health Tech, Biotech
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
11.2 Capital, Delin Ventures, Playfair, AlbionVC
-
Contact
•••••@umed.io
Unlock contact info
Cell therapy development paltform.
-
Latest Funding
$18 Million · Series A
-
Industries
Biotech, Deep Tech
-
Locations
Stockholm
-
Employees
11 to 50
-
Investors
Lauxera Capital Partners
-
Contact
•••••@biolamina.com
Unlock contact info
Developing next generation ‘biopesticides’ based on natural microorganisms.
-
Latest Funding
$77 Million · Series C
-
Industries
Agritech, Biotech
-
Locations
Ghent
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Bill & Melinda Gates Foundation, Innovation Industries, SFPIM, Korys, V-Bio Ventures, VIB, Astanor Ventures, PMV
-
Contact
•••••@aphea.bio
Unlock contact info
Click-to-Release chemistry designed to deliver effective and safe systemic therapies.
-
Latest Funding
$65 Million · Series A
-
Industries
Health Tech, Biotech
-
Locations
Arnhem
-
Employees
1 to 10
-
Investors
Ysios Capital, New Enterprise Associates
-
Contact
•••••@tagworkspharma.com
Unlock contact info
Immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.
-
Latest Funding
$68 Million · Series C
-
Industries
Health Tech, Biotech
-
Locations
London
-
Employees
101 to 250
-
Business Model
B2B
-
Investors
Syncona Partners LLP, Sixth Element Capital, Boxer Capital, Invus, Forbion Capital Partners, AlbionVC
-
Contact
•••••@achillestx.com
Unlock contact info
Automata is a biotechnology company that provides workflow automation for the life sciences industry.
-
Latest Funding
$50 Million · Series B
-
Industries
Health Tech, Biotech, Deep Tech, Data and Analytics, Robotics, Manufacturing, Business Intelligence
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Latitude, Isomer Capital, Aldea VC, Local Globe, Octopus Ventures, Hummingbird Ventures, Firstminute Capital, HCVC, Entrepreneur First
-
Contact
•••••@automata.tech
Unlock contact info
CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.
-
Latest Funding
$50 Million · Series A
-
Industries
Health Tech, AI, Biotech, Data and Analytics
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
General Catalyst, Khosla Ventures
-
Contact
•••••@charmtx.com
Unlock contact info
Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.
-
Latest Funding
$46 Million
-
Industries
Health Tech, Biotech
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Bioqube Ventures
-
Contact
•••••@egle-tx.com
Unlock contact info
Bio alternative to fossil-based and energy–intensive chemical production.
-
Latest Funding
$22 Million · Series B
-
Industries
Health Tech, Biotech
-
Locations
Stockholm
-
Employees
51 to 100
-
Business Model
B2B
-
Investors
Sofinnova Partners, SEB Venture Capital, Industrifonden
-
Contact
•••••@enginzyme.com
Unlock contact info
Eyevensys creates ophthalmic therapeutic bio factories to sustainably treat major eye diseases.
-
Latest Funding
$12 Million · Series B
-
Industries
Health Tech, Hardware, Biotech, Manufacturing
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Pureos Bioventures, Karista
-
Contact
•••••@eyevensys.com
Unlock contact info
Quantum simulation platform for drug discovery.
-
Latest Funding
$2.2 Million · Seed
-
Industries
Health Tech, Biotech
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B, SAAS
-
Investors
ACF Investors, Ascension Ventures
-
Contact
•••••@kuano.ai
Unlock contact info
LabGenius is a biopharmaceutical company developing protein therapeutics using a machine learning-driven evolution engine.
-
Latest Funding
$25 Million
-
Industries
Health Tech, AI, Biotech, Deep Tech, Machine Learning, Robotics, Manufacturing
-
Locations
London
-
Employees
51 to 100
-
Business Model
B2B
-
Investors
Kindred Capital, Atomico
-
Contact
•••••@labgeni.us
Unlock contact info
Manufacturer of medicines to protect from the threat of respiratory viruses
-
Latest Funding
$140 Million · Series B
-
Industries
Health Tech, Biotech, Deep Tech
-
Locations
Amsterdam
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
SoftBank Group, GV
-
Contact
•••••@leydenlabs.com
Unlock contact info
Innovative therapeutic drugs to treat inflammatory, metabolic and liver diseases.
-
Latest Funding
$80 Million · Series C
-
Industries
Health Tech, Biotech
-
Locations
Amsterdam
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Ysios Capital, Forbion Capital Partners, Sofinnova Partners, Novo A/S
-
Contact
•••••@northseatherapeutics.com
Unlock contact info
Therapies for leukaemia based on CAR–T.
-
Latest Funding
$7.4 Million · Seed
-
Industries
Health Tech, Biotech
-
Locations
Barcelona
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Invivo Capital Partners
-
Contact
•••••@onechaintx.com
Unlock contact info
Cancer treatment predictor software.
-
Latest Funding
$14 Million · Series A
-
Industries
Health Tech, Biotech, Pharma
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Hoxton Ventures, Octopus Ventures, Fly Ventures
-
Contact
•••••@pearbio.com
Unlock contact info
Petroleum-free pigments.
-
Latest Funding
$16 Million · Series A
-
Industries
Climate Tech & Green Tech, Biotech, Energy & Nuclear, Manufacturing
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Bpifrance, Elaia
-
Contact
•••••@pili.bio
Unlock contact info
ReViral is a biotechnology company that develops and offers antiviral therapies for patients.
-
Latest Funding
$44 Million · Series C
-
Industries
Health Tech, Biotech, Pharma
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Andera Partners, Novo A/S
-
Contact
•••••@reviral.co.uk
Unlock contact info
Niodegradable sealants and adhesives for wound closure.
-
Latest Funding
$55 Million · Series D
-
Industries
Health Tech, Hardware, Biotech, Manufacturing
-
Locations
Paris
-
Employees
51 to 100
-
Business Model
B2B
-
Investors
Credit Mutuel, CM-CIC Capital Finance, Omnes Capital, Cathay Innovation, Sofinnova Partners, Bpifrance, Karista
-
Contact
•••••@tissium.com
Unlock contact info
Platform to understand the inner mechanisms of cancer enabling the discovery of novel therapies.
-
Latest Funding
$6 Million · Series A
-
Industries
Health Tech, Biotech
-
Locations
Budapest
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
MassMutual Ventures, Day One Capital, Accel, Atlantic Labs
-
Contact
•••••@turbine.ai
Unlock contact info
Precision software for eye surgery.
-
Latest Funding
$8.1 Million · Seed
-
Industries
Health Tech, Biotech
-
Locations
London
-
Employees
1 to 10
-
Investors
Redalpine
-
Contact
•••••@hypervisionsurgical.com
Unlock contact info
Personalized immunotherapy.
-
Latest Funding
$27 Million · Debt Financing
-
Industries
Health Tech, Biotech
-
Locations
Stockholm
-
Employees
11 to 50
-
Investors
European Investment Bank
-
Contact
•••••@anocca.com
Unlock contact info
Biotech company focused on developing products for therapy, diagnostic imaging, and other applications.
-
Latest Funding
$21 Million · Debt Financing
-
Industries
Biotech
-
Locations
Stockholm
-
Employees
11 to 50
-
Investors
European Investment Bank
-
Contact
•••••@affibody.com
Unlock contact info
AI-dirven clinical biology.
-
Latest Funding
$15 Million · Series A
-
Industries
Biotech
-
Locations
Paris
-
Employees
11 to 50
-
Investors
Sofinnova Partners
-
Contact
•••••@kiro.bio
Unlock contact info
Precision therapeutics discovery platform.
-
Latest Funding
$6.2 Million · Seed
-
Industries
Biotech
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Hoxton Ventures
-
Contact
•••••@multiomic.uk
Unlock contact info
Clinical-stage radiopharmaceutical biotech.
-
Latest Funding
$23 Million · Seed
-
Industries
Biotech
-
Locations
Oslo
-
Employees
11 to 50
-
Investors
F-Prime Capital
-
Contact
•••••@artbio.com
Unlock contact info
Restore sight by replacing engineered cell-based therapeutics.
-
Latest Funding
$70 Million · Series A
-
Industries
Biotech
- Locations
-
Employees
11 to 50
-
Investors
British Patient Capital, F-Prime Capital, Eight Roads Ventures, Sofinnova Partners
-
Contact
•••••@tenpointtherapeutics.com
Unlock contact info
Manufacturer of sustainable biological binding of materials.
-
Latest Funding
$11 Million · Series B
-
Industries
Biotech, Deep Tech
-
Locations
Munich
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
HG Ventures, High-Tech Gründerfonds
-
Contact
•••••@bind-x.com
Unlock contact info
Interceptive therapies for heart failure subpopulations.
-
Latest Funding
$70 Million · Series A
-
Industries
Health Tech, Biotech
-
Locations
Paris
-
Employees
1 to 10
-
Investors
OrbiMed, Invivo Capital Partners, Omnes Capital
-
Contact
•••••@corteriapharma.com
Unlock contact info
Biopharma developing small molecule therapeutics.
-
Latest Funding
$38 Million · Series A
-
Industries
Health Tech, Biotech
-
Locations
Glasgow
-
Employees
11 to 50
-
Investors
EIC Accelerator, Scottish Investment Bank
-
Contact
•••••@mironid.com
Unlock contact info
Cloud-based clinical data platform.
-
Latest Funding
$45 Million · Series B
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Amsterdam
-
Employees
101 to 250
-
Business Model
B2B, SAAS
-
Investors
Eight Roads Ventures, Inkef Capital
-
Contact
•••••@castoredc.com
Unlock contact info
Immuno-oncology company treats cancer with antibodies.
-
Latest Funding
$42 Million
-
Industries
Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Genetics
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Epidarex Capital, AlbionVC, Novartis Venture Fund
-
Contact
•••••@epsilogen.com
Unlock contact info
Labster is an e-learning company that offers virtual laboratory simulations based on mathematical algorithms.
-
Latest Funding
$47 Million · Series C
-
Industries
Edtech, Hardware, AR / VR, Biotech
-
Locations
Copenhagen
-
Employees
101 to 250
-
Business Model
B2B
-
Investors
Balderton Capital, Northzone, A16Z, Educapital, Swisscom Ventures, AENU, Nordic Makers
-
Contact
•••••@labster.com
Unlock contact info
Manufacturer of medical devices for mechanical Chronic Low Back Pain (CLBP).
-
Latest Funding
$50 Million · Debt Financing
-
Industries
Health Tech, Hardware, Biotech, Manufacturing
-
Locations
Dublin
-
Employees
101 to 250
-
Business Model
B2B
-
Investors
Oxford Finance LLC, Armentum, Sofinnova Partners, Fountain Healthcare Partners, Seventure Partners
-
Contact
•••••@mainstay-medical.com
Unlock contact info
Innovative therapy for difficult-to-treat hematological diseases.
-
Latest Funding
$31 Million
-
Industries
Biotech, Deep Tech
-
Locations
Stockholm
-
Employees
251 to 500
-
Business Model
B2C
-
Investors
European Investment Bank
-
Contact
•••••@oncopeptides.com
Unlock contact info
PathoQuest is a biotech company developing NGS-based metagenomic tests for exhaustive identification of pathogens.
-
Latest Funding
$17 Million · Series B
-
Industries
Health Tech, Biotech
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Eurazeo, Norgine Ventures, Verve Ventures
-
Contact
•••••@pathoquest.com
Unlock contact info
Manufacturer of radio-immunotherapeutic drugs for cancer patients.
-
Latest Funding
$88 Million · Series B
-
Industries
Health Tech, Biotech, Deep Tech, Pharma, Manufacturing
-
Locations
Brussels
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Gimv, Forbion Capital Partners, BioMedPartners, HealthCap, V-Bio Ventures, Novo A/S, Inkef Capital
-
Contact
•••••@precirix.com
Unlock contact info
Manufacturer of oral drugs that specifically inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1).
-
Latest Funding
$41 Million · Series B
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Paris
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
AGORANOV, Bpifrance, Idinvest Partners, Hadean Ventures
-
Contact
•••••@step-ph.com
Unlock contact info
Developer of treatment for diffuse tenosynovial giant cell tumors.
-
Latest Funding
$44 Million
-
Industries
Health Tech, Biotech
-
Locations
Dublin
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Forbion Capital Partners, Gimv, Medicxi, HealthCap
-
Contact
•••••@synoxtherapeutics.com
Unlock contact info
Developer of chemotherapeutic drugs designed to fight against cancer and chronic diseases.
-
Latest Funding
$65 Million
-
Industries
Health Tech, Biotech, Deep Tech
-
Locations
Munich
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
BioMedPartners, Andera Partners, Seventure Partners, Bayern Kapital, Coparion, High-Tech Gründerfonds
-
Contact
•••••@tubulis.com
Unlock contact info
Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions
-
Latest Funding
$44 Million
-
Industries
Health Tech, Biotech, Manufacturing
-
Locations
Brussels
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
TheClubDeal
-
Contact
•••••@univercells.com
Unlock contact info
Protein-based vaccines.
-
Latest Funding
$7.8 Million · Series A
-
Industries
Biotech
-
Locations
Paris
-
Employees
1 to 10
-
Investors
In-Q-Tel
-
Contact
•••••@linkinvax.com
Unlock contact info
Protein discovery research and manufacturing.
-
Latest Funding
$20 Million · Series A
-
Industries
Biotech, Deep Tech
-
Locations
London
-
Employees
11 to 50
-
Investors
SYSTEMIQ
-
Contact
•••••@basecamp-research.com
Unlock contact info
At-home fertility treatment.
-
Latest Funding
$3.2 Million · Seed
-
Industries
Health Tech, Biotech
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2C
-
Investors
Octopus Ventures, QVentures, Calm/Storm Ventures
-
Contact
•••••@beafertility.com
Unlock contact info
Diagnosis and treatment of hard-to-treat cancers.
-
Latest Funding
$25 Million · Series A
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Berlin
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Andera Partners, HealthCap, Pureos Bioventures, Earlybird Venture Capital
-
Contact
•••••@ariceum-therapeutics.com
Unlock contact info
Clinical-stage central nervous system (CNS) technology.
-
Latest Funding
$110 Million · Series B
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Basel
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Forbion Capital Partners, BioMedPartners, Sofinnova Partners
-
Contact
•••••@noemapharma.com
Unlock contact info
Restorative cardiovascular devices.
-
Latest Funding
$14 Million · Series D
-
Industries
Hardware, Biotech
-
Locations
Eindhoven
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Ysios Capital, EIC Accelerator
-
Contact
•••••@xeltis.com
Unlock contact info
Peptides for the treatment of rare endocrine and related diseases.
-
Latest Funding
$140 Million · Series C
-
Industries
Biotech
-
Locations
Lyon
-
Employees
11 to 50
-
Investors
Intermediate Capital Group, Sofinnova Partners
-
Contact
•••••@amolytpharma.com
Unlock contact info
Chemical discovery digitisation platform.
-
Latest Funding
$43 Million · Series A
-
Industries
Biotech, Manufacturing
-
Locations
Glasgow
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Horizons Ventures, BlueYard Capital
-
Contact
•••••@chemify.io
Unlock contact info
Therapeutic treatment for hearing loss disorders.
-
Latest Funding
$38 Million · Series B
-
Industries
Health Tech, Biotech
-
Locations
Montpellier
-
Employees
11 to 50
-
Business Model
B2C
-
Investors
Invus, Sofinnova Partners
-
Contact
•••••@sensorion.com
Unlock contact info